Emergence of KPC variants from clinical origin associated with reduced susceptibility to ceftazidime- avibactam, including four novel blaKPC-2 variants

Emergence of KPC variants from clinical origin associated with reduced susceptibility to ceftazidime- avibactam, including four novel blaKPC-2 variants.

32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) -April 23-26 – Lisbon, Portugal.

Publicado en: Presentaciones a congresos, Publicaciones
Archivo de la Categoría